Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting

Registered drug

Study on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Semaglutide

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting

Investigational

Study on the Effectiveness of NNC0194-0499 and Semaglutide in Treating Non-Alcoholic Steatohepatitis (NASH) in Patients with Fibrosis Stages 2-4

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Cagrilintide

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting

Registered drug

Safety, Tolerability and Pharmacokinetics of MK-7480 and Diltiazem Hydrochloride in Healthy Adult Male Participants for Non‑alcoholic Steatohepatitis

Registered drug

Belgium

Participants:18–64 years · Healthy volunteers
Substances:Diltiazem Hydrochloride

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting

Investigational

Study on Efinopegdutide for Adults with Compensated Cirrhosis Due to Metabolic Dysfunction-Associated Steatohepatitis

Investigational

France

Participants:18–64 years · 65+ years
Substances:Efinopegdutide

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting

Investigational

Study on AZD2693 for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis and PNPLA3 Genetic Marker

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Azd2693 Sodium

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis

Not recruiting

Investigational

Study on the Effects of Pemafibrate and Tofogliflozin in Patients with Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis

Investigational

Bulgaria

Participants:18–64 years
Substances:Pemafibrate

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting

Investigational

Study on Fecal Microbiota Capsules vs. Placebo for Treating Non-Alcoholic Steatohepatitis in Patients

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Allogeneic Faecal Microbiota, Pooled

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting

Investigational

Study on the Safety and Effects of AZD4831 for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) with Fibrosis

Investigational

Denmark

Participants:18–64 years · 65+ years
Substances:Azd4831

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting

Registered drug

Study on Efinopegdutide and Semaglutide for Adults with Non-Alcoholic Steatohepatitis (NASH) Before Cirrhosis

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Efinopegdutide

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+3

Not recruiting

Registered drugNo placebo

Study on the Effects of Semaglutide on Insulin Resistance and Lipid Metabolism in Women with Obesity and Non-Alcoholic Fatty Liver Disease

Registered drugNo placebo

Denmark

Participants:18–64 years
Substances:Semaglutide

Contact Research Centre

Find therapies in clinical trials near you – page 2

22 trials match your criteria

Metabolic dysfunction-associated steatohepatitis+1

Study on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3

Metabolic dysfunction-associated steatohepatitis+1

Study on the Effectiveness of NNC0194-0499 and Semaglutide in Treating Non-Alcoholic Steatohepatitis (NASH) in Patients with Fibrosis Stages 2-4

Metabolic dysfunction-associated steatohepatitis+1

Safety, Tolerability and Pharmacokinetics of MK-7480 and Diltiazem Hydrochloride in Healthy Adult Male Participants for Non‑alcoholic Steatohepatitis

Metabolic dysfunction-associated steatohepatitis+1

Study on Efinopegdutide for Adults with Compensated Cirrhosis Due to Metabolic Dysfunction-Associated Steatohepatitis

Metabolic dysfunction-associated steatohepatitis+1

Study on AZD2693 for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis and PNPLA3 Genetic Marker

Metabolic dysfunction-associated steatohepatitis

Study on the Effects of Pemafibrate and Tofogliflozin in Patients with Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis

Metabolic dysfunction-associated steatohepatitis+1

Study on Fecal Microbiota Capsules vs. Placebo for Treating Non-Alcoholic Steatohepatitis in Patients

Metabolic dysfunction-associated steatohepatitis+1

Study on the Safety and Effects of AZD4831 for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) with Fibrosis

Metabolic dysfunction-associated steatohepatitis+1

Study on Efinopegdutide and Semaglutide for Adults with Non-Alcoholic Steatohepatitis (NASH) Before Cirrhosis

Metabolic dysfunction-associated steatohepatitis+3

Study on the Effects of Semaglutide on Insulin Resistance and Lipid Metabolism in Women with Obesity and Non-Alcoholic Fatty Liver Disease

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.